Case Study
Infusion care without the road trip
The challenge
Dave lives in a rural area of the Pacific Northwest and was diagnosed with gout. His care team prescribed Krystexxa, an infusion therapy administered every two weeks.
Dave’s only treatment option required driving more than four hours round trip to a hospital system every other week. The travel time and disruption quickly became unsustainable, both personally and financially, making it difficult to stay on track with treatment.
The Leap solution
Seeking a more accessible option, Dave was referred to Leap through a large employer TPA.
A Leap Care Guide partnered with Dave, his prescribing physician, and the employer TPA to coordinate in-home infusion care. Within one week:
• Dave’s first Krystexxa infusion was scheduled and delivered at home
• A licensed infusion nurse was assigned
• Ongoing infusions were scheduled every two weeks to support adherence
Patient impact
By eliminating the need to travel, Leap made it easier for Dave to stay consistent with treatment while minimizing disruption to his daily life and family time.
Employer impact
By avoiding hospital-based infusion care and supporting treatment adherence through home infusion, Leap Health helped Dave’s employer realize $711,000 in claims-validated annual savings.
The patient experience drives employer outcomes
Better patient experiences and stronger employer outcomes are correlated. Patients who stay engaged with a Care Guide are more likely to complete treatment and manage their condition, and that shows up on the employer side as:
- Claims savings
- Steadier attendance
- Fewer benefits questions landing on HR’s desk
More than 45% of total member engagement comes from personalized Care Guide support, saving members close to 3 hours per treatment they would otherwise spend chasing authorizations and sitting in waiting rooms.
Check out our blog post to learn more about the value of the patient experience.
Additional impact stories
Dave’s story is unique, but he is one of many patients who have benefitted from Leap. Check out some other patient stories by clicking either of the tiles below.
More insights
Is home infusion safe for immunoglobulin therapy? What patients should know
Whether you've just been prescribed immunoglobulin (Ig) therapy, or you've been getting it at a clin...
The market is moving faster than most infusion strategies can keep up with
Hospital systems have been acquiring independent physician practices at a rapid pace for close to tw...
The $400K signal: What six months of Leap data says about the specialty drug trend
Luka is a child managing pediatric Crohn's disease. His care team prescribed Remicade, an infusion t...
5 steps to implement a specialty infusion therapy program employees will actually use
Choosing the right vendor helps you understand the savings that are possible. But the right implemen...
What cancer patients can expect from oncology infusion and injection therapies
When chemotherapy ends for an oncology patient, the nausea and hair loss may ease. But a new phase o...
Bringing relief for Luka: From hospital stays to at-home infusion care
Luka is a child managing pediatric Crohn's disease. His care team prescribed Remicade, an infusion t...
What is home infusion therapy? A guide for patients and their families.
More patients and employers are choosing home infusion as a safe, effective alternative to hospital-...
You don't know what you're buying today with specialty infusion therapy. That’s how the model was built.
A member on Remicade needs an infusion every six to eight weeks. Her employer sees one number on the...
Rising healthcare costs for employers projected to reach historic levels in 2027.
Rising healthcare costs are set to hit their sharpest increase in decades in 2027. See what's actual...
Site of care alone doesn’t guarantee savings. Dependable pricing does.
For two years, Matt made a four-hour round trip from his home in Mississippi to an infusion clinic i...